Abstract
Purpose. Nanospheres can be utilised for the targeting of drugs and diagnostic agents to the regional lymph nodes. The surface modification of model polystyrene, (PS), and poly(lactide-co-glycolide),(PLGA), nanospheres by poly(lactide)-poly(ethylene glycol), (PLA:PEG), copolymers has been assessed by in vitro characterisation and in vivobiodistribution studies following subcutaneous administration of the nanospheres to the rat.
Methods. Three PLA: PEG copolymers were investigated, with PEG chain lengths of 750, 2000 and 5000 Da. The PLA:PEG copolymers were either coated onto the surface of PS and PLGA nanospheres or used as a co-precipitate in the formation of PLGA-PLA:PEG nanospheres. Coating of the nanospheres was confirmed by an increase in their particle size and a corresponding decrease in the surface potential. The kinetics of injection site drainage and lymph node retention was determined over a 24 hour time course for naked, coated and co-precipitated nanosphere systems.
Results. Dependent on the surface characteristics, the distribution of the nanospheres can be significantly modified and the lymph node localisation dramatically enhanced by coating their surfaces with PLA:PEG copolymers or by producing co-precipitate nanospheres of PLGA and PLA:PEG.
Conclusions. A fully biodegradable nanosphere system has been developed with excellent lymph node targeting characteristics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
A. E. Hawley, S. S. Davis, and L. Illum. Adv. Drug Del. Rev. 17:129–148. (1995).
S. M. Moghimi, A. E. Hawley, N. M. Christy, T. Gray, L. Illum, and S. S. Davis. FEBS Letts. 344:25–30. (1994).
N. M. Christy, S. M. Moghimi, L. Illum, and S. S. Davis. Proceed. Inter. Symp. Control. Rel. Bioact. Mat. 19:355–356. (1992).
J. Khato, A. A. del Campo, and S. S. Sieber. Pharmacology 26:230–240. (1983).
A. Tumer, C. Kirby, J. Senior, and G. Gregoriadis. Biochim. Biophys. Acta. 760:119–125. (1983).
H. M. Patel, K. M. Boodle, and R. Vaughan-Jones. Biochim. Biophys. Acta. 801:76–86. (1984).
S. Mangat and H. M. Patel. Life Sci. 36:1917–1925. (1985).
A. E. Hawley, L. Illum and S. S. Davis. FEBS Letts., 400:319–323 (1997).
S. Stolnik, S. E. Dunn, M. C. Garnett, M. C. Davies, A. G. A. Coombes, D. C. Taylor, M. P. Irving, S. C. Purkiss, T. F. Tadros, S. S. Davis, and L. Illum. Pharm. Res. 11:1800–1808. (1994).
P. D. Scholes, M. C. Davies, L. Illum, and S. S. Davis. Proceed. Inter. Symp. Control. Rel. Bioact. Mat. 19:154–155. (1992).
Y. Huh, G. W. Donaldson, and F. J. Johnston. Radiation Research. 60:42–53. (1974).
H. M. Patel, N. S. Tuzel, and B. E. Ryman. Biochim. Biophys. Acta. 761:142–151. (1983).
L. Bergqvist, S. E. Strand, L. Haftstrom and P. E. Jonsson. In S. S. Davis, L. Illum, J. G. McVie, and E. Tomlinson (eds.), Microspheres and drug therapy. Pharmaceutical, immunological and medical aspects, Elsevier, Amsterdam, 1984.
S. E. Strand and L. Bergqvist, L. Crit. Rev. Ther. Drug Carrier. Syst. 6:211–238. (1989).
L. B. Bangs. Uniform latex particles, Seragen Diagnostics Inc., Indianapolis, 1984.
L. Illum, S. S. Davis, R. H. Muller, E. Mak, and P. West. Life Sci. 40:367–374. (1987).
F. Ikomi, G. Hanna, and G. W. Schmid-Schonbein. Radiology, 196:107–113. (1995).
T. M. Allen, C. B. Hansen, and L. S. S. Guo. Biochim. Biophys. Acta, 1150:9–16. (1993).
S. E. Dunn, A. Brindley, S. S. Davis, M. C. Davies, and L. Illum. Pharm. Res. 11:1015–1022. (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hawley, A.E., Illum, L. & Davis, S.S. Preparation of Biodegradable, Surface Engineered PLGA Nanospheres with Enhanced Lymphatic Drainage and Lymph Node Uptake. Pharm Res 14, 657–661 (1997). https://doi.org/10.1023/A:1012117531448
Issue Date:
DOI: https://doi.org/10.1023/A:1012117531448